{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:56:04Z","timestamp":1790636164999,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Key R&D Program of China","award":["2021YFC2500204"],"award-info":[{"award-number":["2021YFC2500204"]}]},{"name":"National Key R&D Program of China","award":["2021YFC2500200"],"award-info":[{"award-number":["2021YFC2500200"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"DOI":"10.1007\/s40266-026-01337-2","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T09:48:50Z","timestamp":1790588930000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk of Dementia With Renin-Angiotensin System Inhibitors Versus Calcium Channel Blockers in Hypertensive Adults: A Nationwide Multicenter Study"],"prefix":"10.1007","author":[{"given":"Yinfang","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhen","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caoxiang","family":"She","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8267-7909","authenticated-orcid":false,"given":"Sheng","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"1337_CR1","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1001\/jama.2019.4782","volume":"322","author":"Z Arvanitakis","year":"2019","unstructured":"Arvanitakis Z, Shah RC, Bennett DA. Diagnosis and management of dementia: review. JAMA. 2019;322:1589\u201399. https:\/\/doi.org\/10.1001\/jama.2019.4782.","journal-title":"JAMA"},{"key":"1337_CR2","doi-asserted-by":"publisher","unstructured":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022; 7:e105-e125. https:\/\/doi.org\/10.1016\/s2468-2667(21)00249-8.","DOI":"10.1016\/s2468-2667(21)00249-8"},{"key":"1337_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in early Alzheimer\u2019s disease. N Engl J Med. 2023;388:9\u201321. https:\/\/doi.org\/10.1056\/NEJMoa2212948.","journal-title":"N Engl J Med"},{"key":"1337_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26199529","author":"V Papaliagkas","year":"2025","unstructured":"Papaliagkas V. Anti-amyloid therapies for Alzheimer\u2019s disease: progress, pitfalls, and the path ahead. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26199529.","journal-title":"Int J Mol Sci"},{"key":"1337_CR5","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/s0140-6736(24)01296-0","volume":"404","author":"G Livingston","year":"2024","unstructured":"Livingston G, Huntley J, Liu KY, Costafreda SG, Selb\u00e6k G, Alladi S, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet (London, England). 2024;404:572\u2013628. https:\/\/doi.org\/10.1016\/s0140-6736(24)01296-0.","journal-title":"Lancet (London, England)"},{"key":"1337_CR6","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.125.26119","author":"JA Bastrup","year":"2025","unstructured":"Bastrup JA, Rippe C, Sw\u00e4rd K, Jepps T. Temporal proteomic remodeling of cerebral arteries in male hypertensive rats. Hypertension (Dallas, Tex: 1979). 2025. https:\/\/doi.org\/10.1161\/hypertensionaha.125.26119.","journal-title":"Hypertension (Dallas, Tex: 1979)"},{"key":"1337_CR7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s12017-025-08886-6","volume":"27","author":"J Liu","year":"2025","unstructured":"Liu J, Hou J, Wu J, Chen W. Hypertension Induces Cognitive Impairment and Alterations of Acetylcholine Receptor mRNA Expression in the Hippocampus and Cortex of Mice. NeuroMol Med. 2025;27:64. https:\/\/doi.org\/10.1007\/s12017-025-08886-6.","journal-title":"NeuroMol Med"},{"key":"1337_CR8","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13195-024-01467-y","volume":"16","author":"H Li","year":"2024","unstructured":"Li H, Wang M, Qian F, Wu Z, Liu W, Wang A, et al. Association between untreated and treated blood pressure levels and cognitive decline in community-dwelling middle-aged and older adults in China: a longitudinal study. Alzheimer\u2019s Res Therapy. 2024;16:104. https:\/\/doi.org\/10.1186\/s13195-024-01467-y.","journal-title":"Alzheimer's Res Therapy"},{"key":"1337_CR9","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/s0140-6736(98)03086-4","volume":"352","author":"F Forette","year":"1998","unstructured":"Forette F, Seux ML, Staessen JA, Thijs L, Birkenh\u00e4ger WH, Babarskiene MR, et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet (London, England). 1998;352:1347\u201351. https:\/\/doi.org\/10.1016\/s0140-6736(98)03086-4.","journal-title":"Lancet (London, England)"},{"key":"1337_CR10","doi-asserted-by":"publisher","first-page":"4980","DOI":"10.1093\/eurheartj\/ehac584","volume":"43","author":"R Peters","year":"2022","unstructured":"Peters R, Xu Y, Fitzgerald O, Aung HL, Beckett N, Bulpitt C, et al. Blood pressure lowering and prevention of dementia: an individual patient data meta-analysis. Eur Heart J. 2022;43:4980\u201390. https:\/\/doi.org\/10.1093\/eurheartj\/ehac584.","journal-title":"Eur Heart J"},{"key":"1337_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15092290","author":"DC Ababei","year":"2023","unstructured":"Ababei DC, Bild V, Macadan I, Vasincu A, Rusu RN, Blaj M, et al. Therapeutic implications of renin-angiotensin system modulators in Alzheimer\u2019s dementia. Pharmaceutics. 2023. https:\/\/doi.org\/10.3390\/pharmaceutics15092290.","journal-title":"Pharmaceutics"},{"key":"1337_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-024-01409-4","author":"KM Nist","year":"2024","unstructured":"Nist KM, Bard H, McBride B, Capriglione AL, Moreira JD, Farb DH, et al. Losartan attenuates sex-dependent hypertension, neuroinflammation, and cognitive impairment in the aging male sprague-dawley rat. GeroScience. 2024. https:\/\/doi.org\/10.1007\/s11357-024-01409-4.","journal-title":"GeroScience"},{"key":"1337_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105515","volume":"166","author":"L Scotti","year":"2021","unstructured":"Scotti L, Bassi L, Soranna D, Verde F, Silani V, Torsello A, et al. Association between renin-angiotensin-aldosterone system inhibitors and risk of dementia: a meta-analysis. Pharmacol Res. 2021;166:105515. https:\/\/doi.org\/10.1016\/j.phrs.2021.105515.","journal-title":"Pharmacol Res"},{"key":"1337_CR14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.neulet.2016.05.003","volume":"624","author":"S Zhuang","year":"2016","unstructured":"Zhuang S, Wang HF, Li J, Wang HY, Wang X, Xing CM. Renin-angiotensin system blockade use and risks of cognitive decline and dementia: A meta-analysis. Neurosci Lett. 2016;624:53\u201361. https:\/\/doi.org\/10.1016\/j.neulet.2016.05.003.","journal-title":"Neurosci Lett"},{"key":"1337_CR15","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.ijcard.2016.06.215","volume":"220","author":"YC Kuan","year":"2016","unstructured":"Kuan YC, Huang KW, Yen DJ, Hu CJ, Lin CL, Kao CH. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers reduced dementia risk in patients with diabetes mellitus and hypertension. Int J Cardiol. 2016;220:462\u20136. https:\/\/doi.org\/10.1016\/j.ijcard.2016.06.215.","journal-title":"Int J Cardiol"},{"key":"1337_CR16","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1111\/dom.14838","volume":"24","author":"W Wharton","year":"2022","unstructured":"Wharton W, Anderson A, Hayden KM, Carmichael OT, Clark JM, Luchsinger JA, et al. Effect of renin-angiotensin system antihypertensive medication use on cognitive function in diabetes mellitus with obesity or overweight: an ancillary study to the Action for Health in Diabetes (Look AHEAD) trial. Diabetes Obes Metab. 2022;24:2443\u201353. https:\/\/doi.org\/10.1111\/dom.14838.","journal-title":"Diabetes Obes Metab"},{"key":"1337_CR17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/s1474-4422(19)30393-x","volume":"19","author":"J Ding","year":"2020","unstructured":"Ding J, Davis-Plourde KL, Sedaghat S, Tully PJ, Wang W, Phillips C, et al. Antihypertensive medications and risk for incident dementia and Alzheimer\u2019s disease: a meta-analysis of individual participant data from prospective cohort studies. Lancet Neurol. 2020;19:61\u201370. https:\/\/doi.org\/10.1016\/s1474-4422(19)30393-x.","journal-title":"Lancet Neurol"},{"key":"1337_CR18","unstructured":"Current database. China Renal Data System."},{"key":"1337_CR19","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.7326\/m24-0178","volume":"177","author":"S Zhou","year":"2024","unstructured":"Zhou S, Chen R, Liu J, Guo Z, Su L, Li Y, et al. Comparative effectiveness and safety of atorvastatin versus rosuvastatin\u202f: a multi-database cohort study. Ann Intern Med. 2024;177:1641\u201351. https:\/\/doi.org\/10.7326\/m24-0178.","journal-title":"Ann Intern Med"},{"key":"1337_CR20","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1681\/asn.0000000000000125","volume":"34","author":"X Xu","year":"2023","unstructured":"Xu X, Nie S, Xu H, Liu B, Weng J, Chen C, et al. Detecting neonatal AKI by serum cystatin C. J Am Soc Nephrol. 2023;34:1253\u201363. https:\/\/doi.org\/10.1681\/asn.0000000000000125.","journal-title":"J Am Soc Nephrol"},{"key":"1337_CR21","doi-asserted-by":"publisher","first-page":"510","DOI":"10.3350\/cmh.2021.0332","volume":"28","author":"S Jeong","year":"2022","unstructured":"Jeong S, Oh YH, Choi S, Chang J, Kim SM, Son JS, et al. Association of non-alcoholic fatty liver disease with incident dementia later in life among elder adults. Clin Mol Hepatol. 2022;28:510\u201321. https:\/\/doi.org\/10.3350\/cmh.2021.0332.","journal-title":"Clin Mol Hepatol"},{"key":"1337_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2025.120184","volume":"392","author":"M Wang","year":"2026","unstructured":"Wang M, Yu L, Tong Z, Sun G, Zhang X, Zhang Q, et al. Obesity, metabolic health, and brain health: Insights from a prospective cohort study. J Affect Disord. 2026;392:120184. https:\/\/doi.org\/10.1016\/j.jad.2025.120184.","journal-title":"J Affect Disord"},{"key":"1337_CR23","doi-asserted-by":"publisher","unstructured":"Risk of dementia after initiation of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in adults aged 40-69 years with type 2 diabetes: population based cohort study. BMJ (Clinical research ed) 2024; 386:q1911. https:\/\/doi.org\/10.1136\/bmj.q1911.","DOI":"10.1136\/bmj.q1911"},{"key":"1337_CR24","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604\u201312. https:\/\/doi.org\/10.7326\/0003-4819-150-9-200905050-00006.","journal-title":"Ann Intern Med"},{"key":"1337_CR25","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1016\/s2589-7500(20)30289-2","volume":"3","author":"DR Morales","year":"2021","unstructured":"Morales DR, Conover MM, You SC, Pratt N, Kostka K, Duarte-Salles T, et al. Renin-angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis. The Lancet Digital health. 2021;3:e98\u2013114. https:\/\/doi.org\/10.1016\/s2589-7500(20)30289-2.","journal-title":"The Lancet Digital health"},{"key":"1337_CR26","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/m16-2607","volume":"167","author":"TJ VanderWeele","year":"2017","unstructured":"VanderWeele TJ, Ding P. Sensitivity analysis in observational research: introducing the E-value. Ann Intern Med. 2017;167:268\u201374. https:\/\/doi.org\/10.7326\/m16-2607.","journal-title":"Ann Intern Med"},{"key":"1337_CR27","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1447-0594.2011.00746.x","volume":"12","author":"K Kume","year":"2012","unstructured":"Kume K, Hanyu H, Sakurai H, Takada Y, Onuma T, Iwamoto T. Effects of telmisartan on cognition and regional cerebral blood flow in hypertensive patients with Alzheimer\u2019s disease. Geriatr Gerontol Int. 2012;12:207\u201314. https:\/\/doi.org\/10.1111\/j.1447-0594.2011.00746.x.","journal-title":"Geriatr Gerontol Int"},{"key":"1337_CR28","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/wnf.0000000000000042","volume":"37","author":"E Katada","year":"2014","unstructured":"Katada E, Uematsu N, Takuma Y, Matsukawa N. Comparison of effects of valsartan and amlodipine on cognitive functions and auditory p300 event-related potentials in elderly hypertensive patients. Clin Neuropharmacol. 2014;37:129\u201332. https:\/\/doi.org\/10.1097\/wnf.0000000000000042.","journal-title":"Clin Neuropharmacol"},{"key":"1337_CR29","doi-asserted-by":"publisher","first-page":"e267","DOI":"10.1212\/wnl.0000000000008732","volume":"94","author":"R Peters","year":"2020","unstructured":"Peters R, Yasar S, Anderson CS, Andrews S, Antikainen R, Arima H, et al. Investigation of antihypertensive class, dementia, and cognitive decline: a meta-analysis. Neurology. 2020;94:e267\u201381. https:\/\/doi.org\/10.1212\/wnl.0000000000008732.","journal-title":"Neurology"},{"key":"1337_CR30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/s1474-4422(10)70250-7","volume":"10","author":"C Anderson","year":"2011","unstructured":"Anderson C, Teo K, Gao P, Arima H, Dans A, Unger T, et al. Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies. The Lancet Neurology. 2011;10:43\u201353. https:\/\/doi.org\/10.1016\/s1474-4422(10)70250-7.","journal-title":"The Lancet Neurology"},{"key":"1337_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105378","volume":"109","author":"SK Lundin","year":"2024","unstructured":"Lundin SK, Hu X, Feng J, Lundin KK, Li L, Chen Y, et al. Association between risk of Alzheimer\u2019s disease and related dementias and angiotensin receptor \u2161 blockers treatment for individuals with hypertension in high-volume claims data. EBioMedicine. 2024;109:105378. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105378.","journal-title":"EBioMedicine"},{"key":"1337_CR32","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1161\/hypertensionaha.122.19378","volume":"79","author":"Z Deng","year":"2022","unstructured":"Deng Z, Jiang J, Wang J, Pan D, Zhu Y, Li H, et al. Angiotensin receptor blockers are associated with a lower risk of progression from mild cognitive impairment to dementia. Hypertension (Dallas, Tex: 1979). 2022;79:2159\u201369. https:\/\/doi.org\/10.1161\/hypertensionaha.122.19378.","journal-title":"Hypertension (Dallas, Tex: 1979)"},{"key":"1337_CR33","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/169649","volume":"2012","author":"M Mogi","year":"2012","unstructured":"Mogi M, Iwanami J, Horiuchi M. Roles of brain angiotensin II in cognitive function and dementia. Int J Hypertens. 2012;2012:169649. https:\/\/doi.org\/10.1155\/2012\/169649.","journal-title":"Int J Hypertens"},{"key":"1337_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/biom12101429","author":"W Bild","year":"2022","unstructured":"Bild W, Vasincu A, Rusu RN, Ababei DC, Stana AB, Stanciu GD, et al. Impact of the renin-angiotensin system on the pathogeny and pharmacotherapeutics of neurodegenerative diseases. Biomolecules. 2022. https:\/\/doi.org\/10.3390\/biom12101429.","journal-title":"Biomolecules"},{"key":"1337_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70150","volume":"21","author":"E Widera","year":"2025","unstructured":"Widera E. Falsification periods seen with an immediate reduction in Alzheimer\u2019s disease with semaglutide. Alzheimer\u2019s Dementia. 2025;21:e70150. https:\/\/doi.org\/10.1002\/alz.70150.","journal-title":"Alzheimer's Dementia"},{"key":"1337_CR36","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/jgs.16182","volume":"68","author":"DE Barnes","year":"2020","unstructured":"Barnes DE, Zhou J, Walker RL, Larson EB, Lee SJ, Boscardin WJ, et al. Development and validation of eRADAR: a tool using EHR data to detect unrecognized dementia. J Am Geriatr Soc. 2020;68:103\u201311. https:\/\/doi.org\/10.1111\/jgs.16182.","journal-title":"J Am Geriatr Soc"},{"key":"1337_CR37","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.49370","volume":"6","author":"ZA Marcum","year":"2023","unstructured":"Marcum ZA, Gabriel N, Bress AP, Hernandez I. Association of new use of antihypertensives that stimulate vs inhibit type 2 and 4 angiotensin II receptors with dementia among medicare beneficiaries. JAMA Netw Open. 2023;6:e2249370. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.49370.","journal-title":"JAMA Netw Open"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-026-01337-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-026-01337-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-026-01337-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:03:50Z","timestamp":1790633030000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-026-01337-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":37,"alternative-id":["1337"],"URL":"https:\/\/doi.org\/10.1007\/s40266-026-01337-2","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"assertion":[{"value":"25 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The data that support the findings of this study are available from the corresponding author upon reasonable request.","order":2,"name":"Ethics","label":"Data Availability Statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol received approval from the Medical Ethics Committee of Nanfang Hospital, Southern Medical University (approval no. NFEC2019-213), and informed consent was waived.","order":3,"name":"Ethics","label":"Ethical Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Sheng Nie: Conceptualization, Funding acquisition. Xian Shao: Writing\u2014Review & Editing, Supervision. Hao Wang: Writing\u2014Review & Editing, Supervision. Yinfang Sun: Formal analysis, Data Curation, Writing\u2014Original Draft. Zhixin Guo: Validation, Visualization. Jinming Zhang: Validation, Visualization. Mingzhen Pang: Data Curation, Resources. Ruixuan Chen: Data Curation, Resources. Caoxiang She: Methodology. Shiyu Zhou: Project administration.","order":4,"name":"Ethics","label":"Author Contributions","group":{"name":"EthicsHeading","label":"Declarations"}}]}}